Carolinas HealthCare System

Research and Clinical Trials

Brief Description   The purpose of this study is to assess the maintenance of efficacy of LY2216684 compared with placebo as add on therapy to SSRI among patients with Major Depressive Disorder and patients with partial response to SSRI treatment that met the remission criterion with add on LY2216684 during open-label treatment.
Who may be Eligible   Male or female 18 to 65 with a diagnosis of Major Depressive Disorder
Specialty/Disorder   Major Depressive Disorder
IRBĀ Number   CHS1-11-204
PrincipalĀ Investigator   Tcheremissine, Oleg
For More Information, Contact   Dineen  Gardner , BA
Phone:  (704) 446-7511  Fax:  (704) 446-7505 
Email:  dineen.gardner@carolinashealthcare.org
Address:  465 North Wendover Road Charlotte, NC 28211
About Carolinas HealthCare System
Who We Are
Leadership
Community Benefit
Corporate Financial Information
Diversity and Inclusion
Annual Report
Foundation
Patient Links
Pay Your Bill
Hospital Pre-Registration
Patient Rights
Privacy Policy
Financial Assistance
Quality & Value Reports
Insurance
Careers
Join Carolinas HealthCare System
Physician Careers

For Employees
Carolinas Connect
Connect with Us
Watch Carolinas HealthCare on YoutubeFollow Carolinas HealthCare on TwitterLike Carolinas HealthCare on FacebookContact Carolinas HealthCareJoin Carolinas HealthCare on LinkedInGo to our mobile website.